381 related articles for article (PubMed ID: 32026769)
1. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.
Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z
Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
3. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
4. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
5. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
[TBL] [Abstract][Full Text] [Related]
6. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
8. Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: In silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects.
Baldi A; Chaudhary M; Sethi S; Abhiav ; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2018 Oct; 170():637-647. PubMed ID: 29986259
[TBL] [Abstract][Full Text] [Related]
9. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
10. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
Cherniakov I; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
[TBL] [Abstract][Full Text] [Related]
11. Potentials and challenges in self-nanoemulsifying drug delivery systems.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Expert Opin Drug Deliv; 2012 Oct; 9(10):1305-17. PubMed ID: 22954323
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs.
Patel P; Patel M
Recent Pat Nanotechnol; 2021; 15(2):154-164. PubMed ID: 32912129
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of solid lipid nanoparticles-a review.
Parhi R; Suresh P
Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
[TBL] [Abstract][Full Text] [Related]
15. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
Kothapalli P; Vasanthan M
Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
[TBL] [Abstract][Full Text] [Related]
16. Nanonization techniques to overcome poor water-solubility with drugs.
Da Silva FLO; Marques MBF; Kato KC; Carneiro G
Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
18. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
[TBL] [Abstract][Full Text] [Related]
19. BCS class IV drugs: Highly notorious candidates for formulation development.
Ghadi R; Dand N
J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanocarriers in drug delivery: characterization and design.
Mu H; Holm R
Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]